Merck announced groundbreaking data from three Phase III clinical trials at the CROI 2026 conference.
Show original
These trials aim to evaluate the efficacy and safety of its experimental once-daily dual-drug regimen—Doravirine/Islatravir—for the treatment of adults with HIV-1 infection.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Schmidt: Inflation Remains a Key Issue for the Federal Reserve, No Clear Monetary Policy Response Yet
Chaincatcher•2026/02/25 18:46
Trending news
MoreChicago Mercantile Exchange (CME) announces that the trading hours for natural gas futures and options on its electronic trading platform Globex will be adjusted.
According to a legal group, Louisiana's utility regulators have officially rejected an environmental law organization's request to investigate the $27 billion Meta Platforms, Inc. data center deal.
Crypto prices
More
Bitcoin
BTC
$68,962.45
+7.02%
Ethereum
ETH
$2,071
+11.74%
Tether USDt
USDT
$1
+0.00%
XRP
XRP
$1.47
+8.08%
BNB
BNB
$632.53
+7.42%
USDC
USDC
$1
-0.00%
Solana
SOL
$89.47
+13.83%
TRON
TRX
$0.2863
+1.25%
Dogecoin
DOGE
$0.1042
+13.07%
Cardano
ADA
$0.3086
+18.46%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now